113 related articles for article (PubMed ID: 2881309)
1. Quipazine-metoclopramide inhibition of CB-154-induced prolactin suppression in rats: neurotransmitter-metabolite correlations.
Lipham LB; Porter JK; Norred WP; Booth NH; Robbins JD
Proc Soc Exp Biol Med; 1987 Mar; 184(3):250-5. PubMed ID: 2881309
[TBL] [Abstract][Full Text] [Related]
2. Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
Lipham LB; Booth NH; Jernigan AD; Robbins JD; Hatch RC
Am J Vet Res; 1986 May; 47(5):1089-91. PubMed ID: 3717731
[TBL] [Abstract][Full Text] [Related]
3. Effects of metoclopramide and quipazine on serum prolactin concentrations in steers.
Lipham LB; Thompson FN; Stuedemann JA
J Vet Pharmacol Ther; 1992 Mar; 15(1):78-84. PubMed ID: 1573708
[TBL] [Abstract][Full Text] [Related]
4. Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine.
Fuller RW; Snoddy HD; Mason NR; Hemrick-Luecke SK; Clemens JA
J Pharmacol Exp Ther; 1981 Sep; 218(3):636-41. PubMed ID: 6167711
[No Abstract] [Full Text] [Related]
5. The combined effect of quipazine and haloperidol on plasma prolactin release.
Feigenbaum J; Yanai J; Klawans HL; Chatterton R
Int J Neurosci; 1983; 18(1-2):37-40. PubMed ID: 6840980
[TBL] [Abstract][Full Text] [Related]
6. Effects of the serotonin agonist, quipazine, on luteinizing hormone and prolactin release: evidence for serotonin-catecholamine interactions.
Lynch CO; Johnson MD; Crowley WR
Life Sci; 1984 Oct; 35(14):1481-7. PubMed ID: 6148678
[TBL] [Abstract][Full Text] [Related]
7. The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
Jacoby JH; Poulakos JJ
J Pharm Pharmacol; 1977 Dec; 29(12):771-3. PubMed ID: 22629
[No Abstract] [Full Text] [Related]
8. Dopamine agonist- and antagonist-induced modulation of pituitary gonadotrophin releasing hormone receptors are independent of changes in serum prolactin.
Clayton RN; Bailey LC
J Endocrinol; 1984 Aug; 102(2):215-23. PubMed ID: 6086802
[TBL] [Abstract][Full Text] [Related]
9. Quipazine induced wet dog shake behaviour in rats: mechanism of action.
Hiremagalur ; Keshavan JH; Dandiya PC; Gurbani NK
Pharmacol Res Commun; 1980 Sep; 12(8):757-68. PubMed ID: 6160597
[No Abstract] [Full Text] [Related]
10. Prolactin and luteinizing hormone levels of prelaying, laying and postlaying turkey hens following central administration of serotonin and peripheral administration of quipazine maleate.
Hargis BM; Burke WH
Gen Comp Endocrinol; 1984 Jul; 55(1):12-9. PubMed ID: 6235145
[TBL] [Abstract][Full Text] [Related]
11. On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male rat.
Krulich L; Vijayan E; Coppings RJ; Giachetti A; McCann SM; Mayfield MA
Endocrinology; 1979 Jul; 105(1):276-83. PubMed ID: 446410
[No Abstract] [Full Text] [Related]
12. Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats.
Quattrone A; Schettini G; di Renzo G; Tedeschi G; Preziosi P
Brain Res; 1979 Sep; 174(1):71-9. PubMed ID: 487124
[TBL] [Abstract][Full Text] [Related]
13. Effects of metoclopramide and bromocriptine on prolactin secretion in the pregnant ewe.
Fitzgerald BP; Cunningham FJ
J Endocrinol; 1982 Apr; 93(1):41-6. PubMed ID: 7069345
[TBL] [Abstract][Full Text] [Related]
14. Metoclopramide antagonism of 5-hydroxytryptophan-induced "wet-dog" shake behaviour in the rat.
Fozard JR; Palfreyman MG
Naunyn Schmiedebergs Arch Pharmacol; 1979 Jun; 307(2):135-42. PubMed ID: 314597
[No Abstract] [Full Text] [Related]
15. Is there a "serotonergic syndrome" in neonatal rat pups?
Ristine LA; Spear LP
Pharmacol Biochem Behav; 1985 Feb; 22(2):265-9. PubMed ID: 2858868
[TBL] [Abstract][Full Text] [Related]
16. Effects of serotonin-active drugs on prolactin secretion in male rats.
Jagiełło-Wójtowicz E; Załuska W; Szponar J; Surmaczyńska B; Wójcicki M; Kleinrok Z
Pol J Pharmacol Pharm; 1988; 40(1):73-80. PubMed ID: 2467272
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
[TBL] [Abstract][Full Text] [Related]
18. The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells.
Yeo T; Thorner MO; Jones A; Lowry PJ; Besser GM
Clin Endocrinol (Oxf); 1979 Feb; 10(2):123-30. PubMed ID: 34491
[TBL] [Abstract][Full Text] [Related]
19. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
Langlais PJ; Gabay S
J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
[TBL] [Abstract][Full Text] [Related]
20. Effects of metoclopramide on steers grazing endophyte-infected fescue.
Lipham LB; Thompson FN; Stuedemann JA; Sartin JL
J Anim Sci; 1989 Apr; 67(4):1090-7. PubMed ID: 2497097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
